Ross Bjella, Chief Executive Officer
Mr. Bjella has returned to Kelyniam as Chairman and Chief Executive Officer. Ross previously worked for Kelyniam as a consultant and was instrumental in helping the company receive the initial 510K approval and subsequent ISO 13485 certification. Mr. Bjella is the current CEO of Alithias, Inc., a healthcare data analytics company and previously served as the CEO of DDN, a leading outsourced business service company for the pharmaceutical, biotech and medical device industries.
Terrance Kurtenbach, Chief Financial Officer
Mr. Kurtenbach joined Kelyniam in 2020, after a robust career with Deloitte where he served as a US Global Managing Partner, in Life Sciences and Healthcare Tax. Terry's vast knowledge of the healthcare and financial space make him an integral part of the Kelyniam leadership team. Terry is responsible for the reporting and management of all aspects pertaining to the SEC.
Desiree Webb, Chief Operating and Revenue Officer
Ms. Webb has served on the Kelyniam Board of Directors since 2020, and joined Kelyniam full-time as the Chief Operating and Revenue Officer in 2022. Her professional tenure spans over 26 years in healthcare. Prior to Kelyniam, she was the Vice President of Neuroscience and Orthopedics at HCA, where she spent eleven years and garnered expansive experience in the surgical space.
Ms. Webb is tenacious and ethically driven. She holds a Bachelor of Science from the University of Florida, and an MBA in Healthcare Administration.